Arterial Hypertension in Type 2 Diabetes: Pathogenesis and Treatment
- Authors: Mustafa Kanat1, Abdulhalim Senyigit2, Muhammad A Abdul Ghani3
-
View Affiliations Hide Affiliations1 Division of Diabetes, Department of Internal Medicine, University of Istanbul Medeniyet, Goztepe Training and Research Hospital, Istanbul, Turkey. 2 Department of Internal Medicine, Istanbul Biruni University, Istanbul, Turkey 3 Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio,TX, USA
- Source: Novel Strategies and Approaches in Hypertension Therapy , pp 160-172
- Publication Date: October 2019
- Language: English
Arterial Hypertension in Type 2 Diabetes: Pathogenesis and Treatment, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789811422720/chapter-6-1.gif
Diabetes and hypertension are increasing worldwide as an important public health problem. There is a fairly common ground that combines diabetes and hypertension. Especially insulin resistance is very important in this respect. Epidemiological data and randomized clinical trials indicate that appropriate treatment of diabetes and hypertension provides a significant reduction in cardiovascular events. For this reason, it is extremely important that these two diseases be handled separately. ACE inhibitors, ARB blockers, calcium channel blockers and thiazide diuretics are the preferred agents in these patients. For patients with albuminuria, ARB or ACEI should be preferred for renoprotective effects. In patients with resistant hypertension, aldosterone antagonists therapy may be added to present therapy.
-
From This Site
/content/books/9789811422720.chapter-6dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
